✦ LIBER ✦

Single-agent trabectedin as second-line therapy of persistent or recurrent endometrial cancer: Results of a multicenter phase II study

✍ Scribed by D.S. McMeekin; A. Lisyanskaya; M. Crispens; A.M. Oza; P. Braly; D. Doering; E. Bayever; B. Michiels; M. Markman

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase II evaluation of weekly topoteca

✍ James V. Fiorica; John A. Blessing; Louis V. Puneky; Angeles Alvarez Secord; Jam 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 142 KB

704 - Phase II studies of two trial regi

✍ D. Spaëth; J. Bonneterre; M. Marty; D. Khayat; T. Facchini; T. Conroy 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 215 KB

Single-agent irinotecan or 5-fluorouraci

✍ Stephen J. Clarke; Sonia Yip; Chris Brown; Guy A. van Hazel; David T. Ransom; Da 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 530 KB

Phase 2, Multicenter, Single-Arm Study o

✍ Wilks, Sharon; Puhalla, Shannon; O'Shaughnessy, Joyce; Schwartzberg, Lee; Berrak 📂 Article 📅 2014 🏛 CIG Media Group, LP. 🌐 English ⚖ 169 KB

A multicenter phase II study of beloteca

✍ Rhee, Chin Kook; Lee, Sang Haak; Kim, Ju Sang; Kim, Seung Joon; Kim, Seok Chan; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 169 KB

A Phase II Trial of Prolonged Oral Etopo

✍ Peter G. Rose; John A. Blessing; George S. Lewandowski; William T. Creasman; Ken 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 68 KB